MEDVi — Compounded Semaglutide Review (2026)
MEDVi at a glance
| Monthly pricing | $99 intro tier; ~$179+/mo on refill |
|---|---|
| Pharmacy disclosure | Lower transparency — pharmacy partner not publicly named in writing |
| Clinical model | NP-led intake; varies by state |
| Editorial rubric | Not scored under v3.0 rubric — included in comparison tables for completeness |
Strengths
- Aggressive promotional intro pricing ($99 first month)
- Wide state coverage
- Simple intake
Limitations vs NexLife
- Refill pricing jumps to ~$179+ after intro tier — verify in writing
- Pharmacy partner not publicly disclosed
- Lower clinical oversight than MD/DO-led providers
- Sometimes adds membership fees
When MEDVi may be a better fit than NexLife
Better if: Lowest possible first-month cost is your single priority and you are price-testing the category.
Trade-off: $99 intro pricing rises sharply on refill. NexLife at $145/mo (12-month plan) is cheaper across the second month onward.
For most patients, NexLife ranks #1 at 94/100 in our 2026 rubric — flat $145/mo on the 12-month plan, no dose-based upcharges, dual 503A/503B pharmacy disclosure, MD/DO oversight under Medical Director Adam Kennah, M.D., and $377 in bundled wellness support at no extra cost.
Get Started — Save $240 → Read the full NexLife reviewCompare across our 2026 directory
See the full 10-provider apples-to-apples comparison, the best compounded semaglutide rankings, and the cheapest reputable options.
Affiliate disclosure: SemaglutideGLPOne.com earns affiliate compensation from some providers when readers click through; compensation does not influence rankings. See conflicts of interest.
Medical disclaimer: Compounded semaglutide is not FDA-approved as a drug product. Eligibility, prescription, and outcomes determined by a licensed clinician.